RESEARCH
LANDMARK PUBLICATIONS
/ REVIEWS & CLINICAL PRACTICE GUIDELINES
/ REVIEWS & CLINICAL PRACTICE GUIDELINES
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline Gastroenterología y Hepatología 2018;41:328-349
Pubmed abstract
Pubmed abstract
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul JL, Schirmacher P, Vilgrain V J Hepatology 2018;:doi: 10.1016/j.jhep.2018.03.019
Pubmed abstract
Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul JL, Schirmacher P, Vilgrain V J Hepatology 2018;:doi: 10.1016/j.jhep.2018.03.019
Pubmed abstract
Hepatocellular Carcinoma
Alejandro Forner, María Reig, Jordi Bruix The Lancet 2017;10127:1301-1314
Pubmed abstract
Alejandro Forner, María Reig, Jordi Bruix The Lancet 2017;10127:1301-1314
Pubmed abstract
[Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH] Forner A, Reig M, Varela M, Burrel M, Feliu J, Briceño J, Sastre J, Martí-Bonmati L, Llovet JM, Bilbao JI, Sangro B, Pardo F, Ayuso C, Bru C, Tabernero J, Bruix J. Med Clin (Barc) 2016;
Pubmed abstract
Pubmed abstract
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma Bruix J, Reig M, Sherman M Gastroenterology 2016;
Pubmed abstract
Pubmed abstract
Systemic therapy for hepatocellular carcinoma: the issue of treatment stage migration and registration of progression using the BCLC-refined RECIST. Reig M, Darnell A, Forner A, Rimola J, Ayuso C, Bruix J. Semin Liver Dis. 2014;Nov:34(4):444-55.
Pubmed abstract
Pubmed abstract
Prognosis of hepatocellular carcinoma: the BCLC staging classification. JM. Llovet, C. Brú, J.Bruix. Seminars in Liver Disease 1999;19:329-338
Pubmed abstract
Pubmed abstract
Clinical Management of hepatocellular carcinoma: Conclusions of the Barcelona-2000 EASL Conference. J. Bruix, M. Sherman, JM. Llovet, M. Beaugrand, R. Lencioni, A. Burroughs, E. Christensen, L. Pagliaro, M. Colombo, J. Rodés for the EASL Panel of Experts on HCC. J Hepatol 2001;35:421-430.
Pubmed abstract
Download PDF
Pubmed abstract
Download PDF
Hepatocellular carcinoma. JM. Llovet, A. Burroughs, J. Bruix. Lancet 2003;362:1907-1917
Pubmed abstract
Pubmed abstract
The Barcelona approach:diagnosis, staging and treatment of hepatocellular carcinoma. JM. Llovet, J. Fuster, J. Bruix - Barcelona-Clinic Liver Cancer Group. Liver Transpl. 2004;10:115-120.
Pubmed abstract
Pubmed abstract
Focus on hepatocellular carcinoma. J. Bruix, L. Boix, M. Sala, JM. Llovet. Cancer Cell 2004;5:215-219.
Pubmed abstract
Pubmed abstract
Chemoembolization for hepatocellular carcinoma. J. Bruix, M. Sala, Josep M. Llovet. Gastroenterology 2004;127:179-188.
Pubmed abstract
Pubmed abstract
Management of hepatocellular carcinoma. J Bruix, M Sherman; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Hepatology 2005;42:1208-1236
Pubmed abstract
Download PDF
Pubmed abstract
Download PDF
Design and endpoints of clinical trials in hepatocellular carcinoma. JM Llovet, AM Di Bisceglie, J Bruix, BS Kramer, R Lencioni, AX Zhu, M Sherman, M Schwartz, M Lotze, J Talwalkar, GJ Gores; Panel of Experts in HCC- Design Clinical Trials. J Natl Cancer Inst. 2008;100:698-711.
Pubmed abstract
Pubmed abstract
Molecular targeted therapies in hepatocellular carcinoma. JM Llovet, J Bruix. Hepatology 2008;48:1312-1327
Pubmed abstract
Pubmed abstract
Diagnóstico y tratamiento del Carcinoma hepatocelular. Conferencia de consenso. A Forner, C Ayuso, MI Real, J Sastre, R Robles, B Sangro, M Varela, M dela Mata, M Buti, L Martí-Bonmatí, C Brú, J Tabernero, JM Llovet, J Bruix. Med Clin (Barc) 2009;132:272-287
Pubmed abstract
Pubmed abstract
Hepatocellular carcinoma (HCC): a global perspective. P Ferenci, M Fried, D Labrecque, J Bruix, M Sherman, M Omata, J Heathcote, T Piratsivuth, M Kew, JA Otegbayo, SS Zheng, S Sarin, SS Hamid, SB Modawi, W Fleig, S Fedail, A Thomson, A Khan, P Malfertheiner, G Lau, FJ Carillo, J Krabshuis, A Le Mair. J Clin gastroenterol 2010;44:239-245
Pubmed abstract
Pubmed abstract
World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. P Ferenci, M Fried, D Labrecque, J Bruix, M Sherman, M Omata, J Heathcote, T Piratsivuth, M Kew, JA Otegbayo, SS Zheng, S Sarin, S Hamid, SB Modawi, W Fleig, S Fedail, A Thomson, A Khan, P Malfertheiner, G Lau, FJ Carillo, J Krabshuis, A Le Mair. J Gastrointestin Liver Dis. 2010;19:311-317
Pubmed abstract
Pubmed abstract
Management of hepatocellular carcinoma: an update. J Bruix, M Sherman. Hepatology 2011;53:1020-1022.
Pubmed abstract
Download PDF
Pubmed abstract
Download PDF
Clinical decision making and research in hepatocellular carcinoma: pivotal role of Imaging techniques. J Brix, M Reig, J Rimola, A Forner, M Burrel, R Vilana, C Ayuso. Hepatology 2011;54:2238-2244.
Pubmed abstract
Pubmed abstract
Management of hepatocellular carcinoma. Rodriguez de Lope C, Tremosini S, Forner A, Reig M, Bruix J J Hepatol. 2012;56 :75-87
Pubmed abstract
Pubmed abstract
Hepatocellular Carcinoma. Forner A, Llovet JM, Bruix J. Lancet 2012;379:1245-1255.
Pubmed abstract
Pubmed abstract
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 2012;56:908-943.
Pubmed abstract
Download PDF
Pubmed abstract
Download PDF
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J. Cancer. 2012;48:599-641.
Pubmed abstract
Pubmed abstract
Hepatocellular carcinoma: clinical frontiers and perspectives
Pubmed abstract
Bruix J, Gores GJ, Mazzaferro V.
Gut. 2014;Feb 14.Pubmed abstract